Whang W - Search Results

1

Decision analysis of tamoxifen for the prevention of invasive breast cancer.

Grann VR, Sundararajan V, Jacobson JS, Whang W, Heitjan DF, Antman KH, Neugut AI. Grann VR, et al. Among authors: whang w. Cancer J. 2000 May-Jun;6(3):169-78. Cancer J. 2000. PMID: 10882333

2

Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis.

Grann VR, Jacobson JS, Whang W, Hershman D, Heitjan DF, Antman KH, Neugut AI. Grann VR, et al. Among authors: whang w. Cancer J Sci Am. 2000 Jan-Feb;6(1):13-20. Cancer J Sci Am. 2000. PMID: 10696733

3

Probabilistic sensitivity analysis in cost-effectiveness. An application from a study of vaccination against pneumococcal bacteremia in the elderly.

Whang W, Sisk JE, Heitjan DF, Moskowitz AJ. Whang W, et al. Int J Technol Assess Health Care. 1999 Summer;15(3):563-72. Int J Technol Assess Health Care. 1999. PMID: 10874382

4

Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients.

Grann VR, Panageas KS, Whang W, Antman KH, Neugut AI. Grann VR, et al. Among authors: whang w. J Clin Oncol. 1998 Mar;16(3):979-85. doi: 10.1200/JCO.1998.16.3.979. J Clin Oncol. 1998. PMID: 9508180

5

Benefits and costs of screening Ashkenazi Jewish women for BRCA1 and BRCA2.

Grann VR, Whang W, Jacobson JS, Heitjan DF, Antman KH, Neugut AI. Grann VR, et al. Among authors: whang w. J Clin Oncol. 1999 Feb;17(2):494-500. doi: 10.1200/JCO.1999.17.2.494. J Clin Oncol. 1999. PMID: 10080590

6

Problems with interval estimates of the incremental cost-effectiveness ratio.

Heitjan DF, Moskowitz AJ, Whang W. Heitjan DF, et al. Among authors: whang w. Med Decis Making. 1999 Jan-Mar;19(1):9-15. doi: 10.1177/0272989X9901900102. Med Decis Making. 1999. PMID: 9917015

7

Bayesian estimation of cost-effectiveness ratios from clinical trials.

Heitjan DF, Moskowitz AJ, Whang W. Heitjan DF, et al. Among authors: whang w. Health Econ. 1999 May;8(3):191-201. doi: 10.1002/(sici)1099-1050(199905)8:3<191::aid-hec409>3.0.co;2-r. Health Econ. 1999. PMID: 10348414

8

Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people.

Sisk JE, Moskowitz AJ, Whang W, Lin JD, Fedson DS, McBean AM, Plouffe JF, Cetron MS, Butler JC. Sisk JE, et al. Among authors: whang w. JAMA. 1997 Oct 22-29;278(16):1333-9. JAMA. 1997. PMID: 9343464

9

Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: role of comorbid conditions and race.

Sisk JE, Whang W, Butler JC, Sneller VP, Whitney CG. Sisk JE, et al. Among authors: whang w. Ann Intern Med. 2003 Jun 17;138(12):960-8. doi: 10.7326/0003-4819-138-12-200306170-00007. Ann Intern Med. 2003. PMID: 12809452

10

Risk stratification for coronary bypass surgery in patients with left ventricular dysfunction: analysis of the coronary artery bypass grafting patch trial database.

Argenziano M, Spotnitz HM, Whang W, Bigger JT Jr, Parides M, Rose EA. Argenziano M, et al. Among authors: whang w. Circulation. 1999 Nov 9;100(19 Suppl):II119-24. doi: 10.1161/01.cir.100.suppl_2.ii-119. Circulation. 1999. PMID: 10567289 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

285 results

Search Page

Filters